Kubitza, D., Roth, A., Becka, M., Alatrach, A., Halabi, A., Hinrichsen, H., & Mueck, W. (2013). Effect of hepatic impairment on the pharmacokinetics and pharmacodynamics of a single dose of rivaroxaban, an oral, direct Factor Xa inhibitor. Blackwell Science Inc.

Kubitza, Dagmar, Angelika Roth, Michael Becka, Abir Alatrach, Atef Halabi, Holger Hinrichsen, and Wolfgang Mueck. Effect of Hepatic Impairment On the Pharmacokinetics and Pharmacodynamics of a Single Dose of Rivaroxaban, an Oral, Direct Factor Xa Inhibitor. Blackwell Science Inc, 2013.

Kubitza, Dagmar, et al. Effect of Hepatic Impairment On the Pharmacokinetics and Pharmacodynamics of a Single Dose of Rivaroxaban, an Oral, Direct Factor Xa Inhibitor. Blackwell Science Inc, 2013.